|
BMI
| | |
−0.395 (− 0.248, − 0.123)
|
0.000
|
− 0.287 (− 0.217, − 0.058)
|
0.001
|
|
Lg (Albumin)
| | |
− 0.311 (−7.598, −2.465)
|
0.000
|
− 0.324 (−8.896, − 1.230)
|
0.010
|
|
Lg (Prealbumin)
| | |
− 0.003 (− 0.813, 0.781)
|
0.969
|
0.057 (− 1.104, 1.789)
|
0.639
|
|
Male
| | |
0.024 (− 0.478, 0.694)
|
0.717
|
0.059 (− 0.400, 0.891)
|
0.452
|
|
Age
| | |
0.245 (0.023, 0.083)
|
0.001
|
0.265 (0.021, 0.096)
|
0.002
|
|
Married
| | |
0.073 (−0.246, 0.930)
|
0.252
|
0.091 (−0.273, 1.803)
|
0.238
|
|
Secondary school or below
| | |
−0.030 (− 0.491, 0.306)
|
0.647
|
− 0.096 (− 0.808, 0.210)
|
0.246
|
|
Employed
| | |
0.098 (−0.111, 0.708)
|
0.152
|
0.082 (−0.238, 0.723)
|
0.319
|
|
Year since HIV diagnosis
|
−0.190 (− 0.326, 0.127)
|
0.384
| | |
−0.038 (− 0.232, 0.192)
|
0.851
|
|
ART regimen
|
|
TDF-based regimen
|
0.057 (−0.457, 0.812)
|
0.580
| | |
0.038 (−0.404, 0.643)
|
0.652
|
|
AZT-based regimen
|
0.121 (−0.492, 2.347)
|
0.198
| | |
0.148 (−0.059, 2.314)
|
0.062
|
|
LPV/r-based regimen
|
0.013 (−0.654, 0.742)
|
0.900
| | |
−0.022 (− 0.646, 0.490)
|
0.786
|
|
Years of ART use
|
0.012 (−0.226, 0.239)
|
0.955
| | |
−0.091 (− 0.261, 0.164)
|
0.652
|
|
Comorbidities
|
|
Pneumonia
|
−0.160 (−1.216, 0.153)
|
0.126
| | |
−0.126 (−1.001, 0.163)
|
0.156
|
|
Hepatitis
|
−0.031 (− 1.260, 0.890)
|
0.734
| | |
−0.054 (−1.229, 0.599)
|
0.495
|
|
Tuberculosis
|
−0.154 (−2.189, 0.245)
|
0.116
| | |
−0.120 (−1.752, 0.242)
|
0.136
|
|
Diabetes
|
−0.015 (−1.385, 1.186)
|
0.878
| | |
−0.088 (−1.669, 0.465)
|
0.265
|
|
Syphilis
|
0.115 (−0.594, 2.172)
|
0.260
| | |
0.098 (−0.485, 1.836)
|
0.251
|
|
Cancer
|
0.098 (−0.773, 2.494)
|
0.298
| | |
0.084 (−0.624, 2.094)
|
0.286
|
|
Lg (CD4 count)
|
−0.209 (−1.066, 0.025)
|
0.061
| | |
−0.041 (− 0.586, 0.384)
|
0.680
|
|
Lg (RNA)
|
−0.181 (− 0.672, 0.031)
|
0.074
| | |
−0.186 (− 0.620, − 0.037)
|
0.028
|
